ZeZentalis Pharma

Forecast & Rating10 analysts currently cover ZeZentalis Pharma, with about 50.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $6.67, about 44.0% upside from the current price of $4.63. Price targets range from $4.00 to $10.00 — a wide spread, showing clear disagreement over just how much ZeZentalis Pharma can rise. Historically, about 21.1% of past price targets were eventually met, which adds credibility. For you, this means institutional views on ZeZentalis Pharma are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Jul 27, 2026; for reference only and not investment advice.